• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

RealTimeImage gets $9 million infusion

Article

RealTimeImage netted $9 million in its latest round of financing. The international group of investors included Belgian investment fund Dor, Scitex Corporation, the Challenge Fund, and Intel (through the Intel 64 fund). Dor is funded by

RealTimeImage netted $9 million in its latest round of financing. The international group of investors included Belgian investment fund Dor, Scitex Corporation, the Challenge Fund, and Intel (through the Intel 64 fund). Dor is funded by several international companies involved in the printing industry, including Agfa, Heidelberger, and Scitex. Dor now values RTI at $72 million.


© 2000 Miller Freeman Inc.
12/13/00, Issue # 118, page 7.

Recent Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.